CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,951
- in 4 filings
Net −$117,951. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −662 | $50.24 | $33K | 9,145 |
| 2024-04-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −200 | $50.37 | $10K | 8,945 |
| 2024-04-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −543 | $51.50 | $28K | 8,402 |
| 2024-03-04 | Weinberg Eric Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +92,200 | 92,200 | ||
| 2024-03-04 | Goldshleger Ilya Chief Operating Officer | Grant or award · Stock Option (right to buy) | +92,200 | 92,200 | ||
| 2024-03-04 | Thunen Shelley B Chief Financial Officer | Grant or award · Stock Option (right to buy) | +92,200 | 92,200 | ||
| 2024-03-04 | Kurtz Ronald M MD President & CEO | Grant or award · Stock Option (right to buy) | +149,000 | 149,000 | ||
| 2024-03-01 | Thunen Shelley B Chief Financial Officer | Option exercise 10b5-1 | +10,000 | $15.60 | $156K | 23,691 |
| 2024-03-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −1,166 | $54.95 | $64K | 22,525 |
| 2024-03-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −6,361 | $56.38 | $359K | 16,164 |
| 2024-03-01 | Thunen Shelley B Chief Financial Officer | Sale 10b5-1 | −2,473 | $57.03 | $141K | 13,691 |
| 2024-03-01 | Thunen Shelley B Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 56,805 | ||
| 2024-02-16 | Goldshleger Ilya Chief Operating Officer | Option exercise 10b5-1 | +10,000 | $23.04 | $230K | 36,475 |
| 2024-02-16 | Goldshleger Ilya Chief Operating Officer | Sale 10b5-1 | −5,000 | $55.00 | $275K | 31,475 |
| 2024-02-16 | Goldshleger Ilya Chief Operating Officer | Sale 10b5-1 | −5,000 | $56.00 | $280K | 26,475 |
| 2024-02-16 | Goldshleger Ilya Chief Operating Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 0 | ||
| 2024-02-15 | Goldshleger Ilya Chief Operating Officer | Option exercise 10b5-1 | +10,000 | $23.04 | $230K | 36,475 |
| 2024-02-15 | Goldshleger Ilya Chief Operating Officer | Sale 10b5-1 | −5,000 | $53.00 | $265K | 31,475 |
| 2024-02-15 | Goldshleger Ilya Chief Operating Officer | Sale 10b5-1 | −5,000 | $54.00 | $270K | 26,475 |
| 2024-02-15 | Goldshleger Ilya Chief Operating Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 10,000 |
Page 13 of 15 · 300 trades